Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
1.030
-0.060 (-5.50%)
Aug 14, 2025, 11:40 AM - Market open

Ironwood Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
92.8588.5692.15656.2620.13362.56
Upgrade
Cash & Short-Term Investments
92.8588.5692.15656.2620.13362.56
Upgrade
Cash Growth
-12.01%-3.90%-85.96%5.82%71.04%104.81%
Upgrade
Accounts Receivable
86.1781.89129.12115.46114.04122.35
Upgrade
Receivables
86.1781.89129.12115.46114.04122.35
Upgrade
Prepaid Expenses
12.7311.9212.017.728.699.19
Upgrade
Restricted Cash
---1.251.251.74
Upgrade
Other Current Assets
----1.12-
Upgrade
Total Current Assets
191.75182.37233.29780.63745.23495.84
Upgrade
Property, Plant & Equipment
14.1315.5218.1720.3122.9325.51
Upgrade
Other Intangible Assets
2.452.863.68---
Upgrade
Long-Term Deferred Tax Assets
129.46144.23212.32283.66333.29-
Upgrade
Long-Term Deferred Charges
3.43.92.4---
Upgrade
Other Long-Term Assets
1.752.021.2115.9225.4837.89
Upgrade
Total Assets
342.95350.91471.071,1011,127559.24
Upgrade
Accounts Payable
1.392.137.830.480.940.66
Upgrade
Accrued Expenses
17.272647.2217.7133.2915.77
Upgrade
Current Portion of Long-Term Debt
199.33-199.56-116.86-
Upgrade
Current Portion of Leases
3.223.193.133.073.133.13
Upgrade
Current Income Taxes Payable
0.760.521.240.66--
Upgrade
Current Unearned Revenue
0.982.032.62---
Upgrade
Other Current Liabilities
9.584.9814.53.617.4912.61
Upgrade
Total Current Liabilities
232.5338.85276.125.53161.732.17
Upgrade
Long-Term Debt
385583.99498.31396.25337.33430.26
Upgrade
Long-Term Leases
11.1212.314.5416.618.4820.32
Upgrade
Long-Term Unearned Revenue
5.71.8----
Upgrade
Other Long-Term Liabilities
16.7715.3128.429.773.513.85
Upgrade
Total Liabilities
651.11652.24817.37448.14521.02496.6
Upgrade
Common Stock
0.160.160.160.150.160.16
Upgrade
Additional Paid-In Capital
1,4051,3951,3551,3491,5431,529
Upgrade
Retained Earnings
-1,712-1,698-1,699-696.38-937.61-1,466
Upgrade
Comprehensive Income & Other
-2.030.92-3.03---
Upgrade
Shareholders' Equity
-308.16-301.34-346.3652.38605.9162.64
Upgrade
Total Liabilities & Equity
342.95350.91471.071,1011,127559.24
Upgrade
Total Debt
598.67599.48715.54415.92475.8453.7
Upgrade
Net Cash (Debt)
-505.82-510.92-623.38240.29144.33-91.14
Upgrade
Net Cash Growth
---66.49%--
Upgrade
Net Cash Per Share
-3.15-3.19-4.011.290.88-0.57
Upgrade
Filing Date Shares Outstanding
162.43161.81156.53154.16159.22160.96
Upgrade
Total Common Shares Outstanding
162.43160.21156.35154.03162.04160.62
Upgrade
Working Capital
-40.77143.52-42.81755.1583.53463.67
Upgrade
Book Value Per Share
-1.90-1.88-2.214.243.740.39
Upgrade
Tangible Book Value
-310.62-304.2-349.98652.38605.9162.64
Upgrade
Tangible Book Value Per Share
-1.91-1.90-2.244.243.740.39
Upgrade
Machinery
-3.895.424.234.134.71
Upgrade
Leasehold Improvements
-7.417.417.417.417.41
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q